摘要
目的:比较3种方案治疗慢性乙型肝炎的成本-效果。方法:查阅治疗慢性乙型肝炎的相关文献,按不同的给药方案将其分为3组:干扰素+苦参素(A组)、干扰素+胸腺肽(B组)、拉米夫定+苦参素(C组),3组用药时间均为90d,运用药物经济学原理进行成本-效果分析。结果:3种给药方案的临床疗效无显著性差异,但成本间却存在显著性差异。结论:B组为较佳治疗方案。
OBJECTIVE： To compare the cost- effectiveness of 3 therapeutic schemes in the treatment of the chronic Hepatitis B.METHODS： The medication data for the treatment of the chronic Hepatitis B were investigated, and the therapeutic schemes were divided into 3 groups： Interferon plus sophorcarpidine（Group A）, Interferon plus thymopeptide（Group B） and lamivudine plus ophorcarpidine（Group C） .The medication duration was 90 days for all the 3 groups.The cost- effectiveness analysis was performed using the theory of pharmacoeconomics.RESULTS：The 3 groups showed no significant differences in clinical efficacy,but significant differences in costs were noted.CONCLUSION：Group B is preferable for chronic Hepatitis B in terms of cost- effectiveness.
出处
《中国药房》
CAS
CSCD
北大核心
2007年第17期1292-1293,共2页
China Pharmacy
